EIG
Evercore ISI Group Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
601
StoneCo
STNE
$4.63B
|
SS
Sheriq Sumar
| $17.30 | $23 |
33%
upside
| Outperform | 1 year ago |
|
602
PayPal
PYPL
$65.2B
|
DT
David Togut
| $68.26 | $70 |
3%
upside
| In-Line | 1 year ago |
|
603
Mastercard
MA
$528B
|
DT
David Togut
| $584.22 | $525 |
10%
downside
| Outperform | 1 year ago |
|
604
KeyCorp
KEY
$20.8B
| $18.94 | $16.50 |
13%
downside
| Outperform | 1 year ago |
|
|
605
Jack Henry & Associates
JKHY
$11.8B
|
DT
David Togut
| $162.24 | $175 |
8%
upside
| In-Line | 1 year ago |
|
606
Global Payments
GPN
$21.3B
|
DT
David Togut
| $87.78 | $160 |
82%
upside
| Outperform | 1 year ago |
|
607
Corpay
CPAY
$22.4B
| $316.65 | $345 |
9%
upside
| Outperform | 1 year ago |
|
|
608
Comerica
CMA
$8.85B
| $68.86 | $54 |
22%
downside
| In-Line | 1 year ago |
|
|
609
Alnylam Pharmaceuticals
ALNY
$59.2B
|
LB
Liisa Bayko
| $452 | $260 |
42%
downside
| Outperform | 1 year ago |
|
610
SiriusXM
SIRI
$8.1B
|
VJ
Vijay Jayant
| $24.06 | $32.50 |
35%
upside
| In-Line | 1 year ago |
|
611
Insmed
INSM
$30.7B
|
JS
Josh Schimmer
| $145.10 | $75 |
48%
downside
| Outperform | 1 year ago |
|
612
NextEra Energy, Inc.
NEE
$146B
|
DC
Durgesh Chopra
| $70.90 | $75 |
6%
upside
| In-Line | 1 year ago |
|
613
Mondelez International
MDLZ
$79.9B
| $61.74 | $79 |
28%
upside
| Outperform | 1 year ago |
|
|
614
Liberty Media Series C
FWONK
$25.2B
|
VJ
Vijay Jayant
| $100.75 | $90 |
11%
downside
| Outperform | 1 year ago |
|
615
Magnite
MGNI
$3.54B
|
MM
Mark Mahaney
| $24.85 | $15 |
40%
downside
| Outperform | 1 year ago |
|
616
Wendy's
WEN
$1.97B
|
DP
David Palmer
| $10.33 | $22 |
113%
upside
| In-Line | 1 year ago |
|
617
Savara
SVRA
$643M
| $3.72 | $7 |
88%
upside
| Outperform | 1 year ago |
|
|
618
Eos Energy Enterprises
EOSE
$2.01B
|
JW
James West
| $7.21 | $3 |
58%
downside
| Outperform | 1 year ago |
|
619
Linde
LIN
$220B
|
SR
Stephen Richardson
| $469.52 | $465 |
1%
downside
| Outperform | 1 year ago |
|
620
89bio
ETNB
$1.32B
|
LB
Liisa Bayko
| $8.87 | $33 |
272%
upside
| Outperform | 1 year ago |
|
621
Akero Therapeutics
AKRO
$3.58B
|
LB
Liisa Bayko
| $44.72 | $38 |
15%
downside
| Outperform | 1 year ago |
|
622
Clearway Energy Class C
CWEN
$3.38B
|
ML
Michael Lonegan
| $28.68 | $30 |
5%
upside
| Outperform | 1 year ago |
|
623
Arcellx
ACLX
$4.03B
|
CK
Cory Kasimov
| $72.62 | $85 |
17%
upside
| Outperform | 1 year ago |
|
624
Fluence Energy
FLNC
$989M
|
JW
James West
| $7.55 | $47 |
523%
upside
| Outperform | 1 year ago |
|
625
Onto Innovation
ONTO
$5.1B
|
ML
Mark Lipacis
| $104.07 | $250 |
140%
upside
| Outperform | 1 year ago |
|